# A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

> **NCT00924989** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 139 (actual)

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

- **DRUG:** OSI-906
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00924989
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-01
- **Primary completion:** 2012-07-11
- **Final completion:** 2012-10-08
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924989, "A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00924989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*